The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriuchi, M.
Right arrow Articles by Fauci, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriuchi, M.
Right arrow Articles by Fauci, A. S.
The Journal of Immunology, 1999, 162: 5986-5992.
Copyright © 1999 by The American Association of Immunologists

USF/c-Myc Enhances, While Yin-Yang 1 Suppresses, the Promoter Activity of CXCR4, a Coreceptor for HIV-1 Entry

Masako Moriuchi1,*, Hiroyuki Moriuchi1,2,*, David M. Margolis{dagger} and Anthony S. Fauci*

* Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and {dagger} Institute of Human Virology, University of Maryland, Baltimore, MD 21201


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Transcription factors USF1 and USF2 up-regulate gene expression (i.e., HIV-1 long terminal repeats) via interaction with an E box on their target promoters, which is also a binding site for c-Myc. The c-Myc oncoprotein is important in control of cellular proliferation and differentiation, while Yin-Yang 1 (YY1) has been shown to control the expression of a number of cellular and viral genes. These two proteins physically interact with each other and mutually inhibit their respective biological functions. In this study, we show that USF/c-Myc up-regulates, while YY1 down-regulates the promoter activity of CXCR4, a coreceptor for T cell-tropic HIV-1 entry. We have identified an E box around -260 and a YY1 binding site around -300 relative to the transcription start site. Mutation of the E box abolished USF/c-Myc-mediated up-regulation of CXCR4 promoter activity, and mutation of the YY1 binding site was associated with unresponsiveness to YY1-mediated inhibition. These data suggest that USF/c-Myc and YY1 may play an important role in the HIV-1-replicative cycle, by modulating both the viral fusion/entry process and viral expression.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Anumber of cellular factors of the host have been shown to modulate replication of HIV-1 at various steps of the viral replication cycle (1). At the level of viral expression, numerous cellular transcription factors regulate transcription from the long terminal repeat (LTR),3 the promoter of HIV-1. While many of these factors (i.e., nuclear factor-{kappa}B/Rel family proteins (2), C/EBP (NF-IL6) (3, 4), Sp1 (5), or USF (6)) enhance LTR activity (reviewed in 7), a few factors have been shown to directly reduce HIV expression at the promoter level. YY1, a multifunctional transcription factor, has been shown to repress a number of cellular and viral gene promoters (reviewed in 8), including the HIV-1 LTR (9, 10).

Host cell factors also affect HIV at earlier steps in its replication cycle. HIV-1 entry into cells requires the CD4 molecule as well as a fusion/entry cofactor (11, 12, 13, 14, 15, 16, 17, 18). Several chemokine receptors serve as fusion/entry cofactors, among which CXCR4, a receptor for CXC chemokine stromal-derived factor (SDF-1) (19, 20), is a major fusion/entry cofactor for T cell-tropic HIV-1. Functional expression of CXCR4 is influenced by other host cell factors. SDF-1, a ligand of CXCR4, regulates cell surface expression of CXCR4 (21, 22), whereas IL-2 regulates the steady-state level of CXCR4 mRNA (23). We have recently cloned and analyzed the promoter region of CXCR4 (24), and found that two transcription factors, nuclear respiratory factor-1 (NRF-1) and Sp1, interact with the proximal region of the CXCR4 promoter, and that the former is critical for CXCR4 promoter activity. CXCR4 expression on monocytes has also been shown to be down-regulated upon differentiation of these cells into mature macrophages (25).

In this study, we characterize the further upstream region of the CXCR4 promoter. We report that USF/c-Myc and YY1 bind to the upstream region of the CXCR4 promoter, and positively or negatively regulate the CXCR4 promoter, respectively. Involvement of USF and YY1 at two critical steps of HIV-1 replication, viral fusion/entry and expression, suggests that these transcription factors may play a role in the pathogenesis of HIV disease.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Plasmids

Plasmid pGL-CXCR4(-357) contains the CXCR4 upstream sequence between -357 and +51 relative to the transcription start site (TSS), followed by the luciferase gene (24). Plasmids pGL-CXCR4{Delta}E box and pGL-CXCR4{Delta}YY1 were constructed by PCR-based site-directed mutagenesis (26) to generate mutations on an E box around -260 and on a YY1 binding site around -300 relative to the TSS, respectively (see Table IGo and Fig. 1Go). Plasmid pBpuro-c-myc-ER (a generous gift of T. D. Littlewood, Imperical Cancer Research Fund, London, U.K.) encodes human c-Myc fused to the hormone-binding domain of the mutant murine estrogen receptor. Functional expression of a c-Myc fusion protein by the transfected plasmid is induced by 4-hydroxytamoxifen (10 nM; Sigma, St. Louis, MO) (27). Plasmids pCMV-Myc and pCMV-Max were gifts of D. Ayer (University of Utah, Salt Lake City, UT) (28) and used for in vitro synthesis of c-Myc and Max proteins. USF expression plasmids pSV-USF1 and pSV-USF2 were kindly provided by M. Sawadogo (University of Texas M. D. Anderson Cancer Center, Houston, TX) (29), and a YY1 expression plasmid pCMV-YY1 was a generous gift of T. Shenk (Princeton University, Princeton, NJ) (30).


View this table:
[in this window]
[in a new window]
  		Table I. Oligonucleotides used for gel mobility shift assays and site-directed mutagenesisa

 


View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 1. Schematic diagram of the CXCR4 upstream sequence. Top, The horizontal arrows indicate the transcription start sites (TSS), and numbers above the sequence indicate nucleotide relative to the most 5' TSS. Sequences homologous to binding sites for cellular transcription factors NRF-1, Sp1, AP-1, vitamin D receptor, NF-AT/AP-1, STAT, c-Myc/USF, YY1, nuclear factor-{kappa}B, and serum-responsive factor are indicated. Bottom, The areas protected from DNase I digestion (FP-1 through FP-7) are indicated (see Fig. 2Go). An E box and a YY1 binding site are shown as italic letters, and mutations in pGL-CXCR4{Delta}E box and pGL-CXCR4{Delta}YY1 are shown by the downward arrows (also see Table IGo).

 
Cells

PBMC were obtained from healthy volunteers, as described previously (31). A3.01 human CD4+ T cells were propagated as described previously (24, 32).

Transfection, and luciferase and ß-galactosidase assays

Transient expression and luciferase and ß-galactosidase assays were performed as described previously (32, 33).

DNase I footprinting

DNase I footprinting was performed as described previously (34). Probes used for DNase I footprinting were prepared as follows: a MluI-SacI fragment and a MluI-SphI fragment of pGL-CXCR4(-357) were labeled with [32P]dCTP using Klenow enzyme and gel purified. These fragments span the CXCR4 promoter sequence between -357 and -277, and between -283 and -46, respectively, relative to the TSS. Furthermore, the CXCR4 promoter sequence spanning from -357 and -156 relative to the TSS was amplified with PCR and subcloned into pCR2.1 (Invitrogen, Carlsbad, CA), and a SpeI-EcoRV fragment of the resultant plasmid (in which the SpeI site is located downstream of the 3' end of the CXCR4 promoter sequence position -156) was 32P labeled and purified, as described above.

Nuclear extracts, propagation of transcription factors, and gel-mobility shift assays

Nuclear extracts were prepared from A3.01 cells or U937 cells, as described previously (33). c-Myc, Max, USF-1, and USF-2 proteins were synthesized in vitro from pCMV-Myc, pCMV-Max, pSV-USF1, and pSV-USF2, respectively, using T7 RNA polymerase/Wheat Germ Extract System (Promega, Madison, WI), and rYY1 protein was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Gel-mobility shift assays were performed as described previously (33). Antisera used for supershift assays were the following: normal rabbit serum, anti-YY1 rabbit polyclonal Ab (Santa Cruz Biotechnology), anti-c-Myc rabbit polyclonal Ab (Santa Cruz Biotechnology), anti-USF-1, or anti-USF2 rabbit polyclonal Ab (provided by M. Sawadogo).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Identification of putative cis-acting elements in the upstream region of the CXCR4 promoter

First, we assessed the binding of cellular transcription factors to the CXCR4 promoter region between -350 and -150 relative to the TSS in DNase I footprinting analysis. Among areas protected from DNase I digestion (Figs. 1Go and 2), regions around -260 (FP-5) and -300 (FP-6) were found to share homology to an E box (a binding site for basic region-helix-loop-helix-leucine zipper (bHLHZip) family proteins (35)) and a YY1 binding site (8), respectively.

bHLHZip proteins c-Myc, USF-1, and USF-2 bind to the CXCR4 promoter

To demonstrate that the putative E box in the CXCR4 promoter region actually serves as a binding site for bHLHZip family of transcription factors, gel-mobility shift assays were performed using in vitro synthesized proteins. Either c-Myc/Max, USF-1, or USF-2 protein formed a complex with an L-E box oligonucleotide corresponding to the FP-5 region (Fig. 3GoA); however, c-Myc/Max complex was detectable only after longer exposure (data not shown). c-Myc protein alone could not form a complex with the L-E box oligonucleotide (data not shown), most likely reflecting the fact that Max protein is an obligate heterodimeric partner for c-Myc (35). When A3.01 CD4+ T cell nuclear extracts were used instead of purified proteins, a DNA-protein complex, which was specifically competed by unlabeled probe as well as by an oligonucleotide containing the consensus E box, was formed (Fig. 3GoB). Supershift assays using specific Abs to c-Myc, USF1, or USF2 indicated that the major complex contained both USF1 and USF2, but not c-Myc (Fig. 3GoC). These results indicate that bHLHZip proteins c-Myc, USF1, and USF2 bind to the CXCR4 promoter E box; however, USF1 and USF2 have higher affinity for the E box than does c-Myc.



View larger version (43K):
[in this window]
[in a new window]
  		FIGURE 3. bHLHZip proteins c-Myc, USF1, and USF2 bind to the CXCR4 promoter. A, In vitro synthesized c-Myc, USF1, and USF2 proteins bind to the E box in CXCR4 promoter. L-E box (see Table IGo) probe was incubated with in vitro synthesized c-Myc/Max (lane 3), USF-1 (lane 6), USF2 (lane 7), or control reaction (lanes 2 and 5). Lanes 1 and 4 represent probe alone. Arrows and F. P. indicate DNA-protein complexes and free probe, respectively. B, Gel-mobility shift and competition assays. L-E box probe was incubated with A3.01 nuclear extracts in the presence of a 500-fold molar excess of nonlabeled oligonucleotides (see Table IGo) indicated above the figure as competitors. Lane 1 represents probe alone, and lanes 2–6 represent reactions in the presence of A3.01 nuclear extracts. The arrow represents the DNA-protein complex. C, Supershift assays. Nuclear extracts from A3.01 cells were incubated with the indicated Abs for 30 min on ice before incubation with L-E box probe. The arrow indicates USF complexes, and the solid and open circles indicate the shift of USF1 and USF2 complexes, respectively.

 
bHLHZip proteins c-Myc, USF-1, and USF-2 up-regulate CXCR4 promoter activity

To investigate whether bHLHZip proteins c-Myc, USF1, and USF2, which can bind to the CXCR4 promoter, are capable of regulating expression from the CXCR4 promoter, expression vectors for these proteins were cotransfected with CXCR4 promoter-luciferase reporter constructs. Transfection of c-Myc up-regulated expression from the CXCR4 promoter; this effect was dependent upon the presence of an intact E box (Fig. 4GoA). Cotransfection with the Max expression vector did not further enhance c-Myc-mediated transactivation of the CXCR4 promoter (data not shown), probably because Max is constitutively and abundantly expressed in most cell types (35, 36). USF1, and to a slightly lesser extent, USF2, also increased expression of the CXCR4 promoter reporter gene. Mutation of the E box ablated this effect (Fig. 4GoB).



View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 4. bHLHZip proteins c-Myc, USF1, and USF2 up-regulate CXCR4 promoter activity. A, c-Myc up-regulates CXCR4 promoter activity. Forty million PBMCs were transfected with 20 µg of either pGL-CXCR4(-357) or pGL-CXCR4{Delta}E box along with 20 µg of pBpuro-c-myc-ER, and either untreated (control) or treated (Myc) with 10 nM of 4-hydroxytamoxifen (Sigma) 24 h after transfection. 4-Hydroxytamoxifen at this concentration by itself had no effect on CXCR4 promoter activity (data not shown). Cells were harvested 48 h after transfection for luciferase assays. Fold induction indicates luciferase activity relative to basal promoter activity. Results were representative of four independent experiments. B, USF1 and USF2 up-regulate CXCR4 promoter activity. PBMC were transfected with 20 µg of either pGL-CXCR4(-357) or pGL-CXCR4{Delta}E box along with 20 µg of either pSV2-CAT, pSV-USF1, or pSV-USF2. Results were representative of four independent experiments.

 
YY1 binds to the CXCR4 promoter

To determine whether YY1 actually binds to the region, gel-mobility shift assays were performed using bacterially synthesized YY1 protein. Purified YY1 protein formed a complex with an oligonucleotide corresponding to the FP-6 region (Fig. 5GoA). A3.01 CD4+ T cell nuclear extracts were found to contain two complexes binding to the FP-6 region, which were specifically competed by unlabeled probe; a fast migrating complex, but not a slowly migrating complex, was also specifically competed by an oligonucleotide containing the consensus YY1 binding motif (Fig. 5GoB; Table IGo). Gel-shift interference assays using anti-YY1 Ab confirmed that the fast migrating complex contains YY1 (Fig. 5GoC). Thus, these results clearly indicate that YY1 binds to the CXCR4 promoter. A slowly migrating complex was specifically competed by an oligonucleotide containing the consensus GATA binding motif (Fig. 5GoB); however, Ab to GATA1, GATA2, or GATA3 did not affect the mobility or formation of the complex (data not shown). In addition, the FP-6 region has only limited homology to GATA binding motif. Identification of this complex is currently in progress.



View larger version (46K):
[in this window]
[in a new window]
  		FIGURE 5. YY1 binds to CXCR4 promoter. A, In vitro synthesized YY1 protein binds to CXCR4 promoter. L-YY1 probe was incubated with in vitro synthesized YY1 protein (lane 2) or BSA (lane 3) as a control. B, Gel-mobility shift and competition assays. L-YY1 probe was incubated with A3.01 nuclear extracts in the presence of a 500-fold molar excess of nonlabeled oligonucleotides (see Table IGo) indicated above the figure as competitors. Lane 1 represents probe alone, and lanes 2–8 represent reactions in the presence of A3.01 nuclear extracts. F. P. indicates free probe, and the solid and open arrows indicate the YY1 complex (see C) and another uncharacterized protein-DNA complex, respectively. C, Gel-shift interference analysis with anti-YY1 Ab. The reaction mixture for binding between L-YY1 oligonucleotide and A3.01 nuclear extracts was incubated with either normal rabbit serum (lane 3) or anti-YY1 rabbit polyclonal Ab (lane 4). The solid arrows indicate the YY1 complex, which was disrupted by anti-YY1 Ab (lane 4), but not control serum (lane 3). Lane 1 represents probe alone, and lanes 2–4 represent reactions in the presence of A3.01 nuclear extracts.

 
YY1 suppresses CXCR4 promoter activity

In the context of other promoters, YY1 has been shown to activate transcription, repress transcription, or initiate transcription (reviewed by Shrivastava and Calame, 8). To investigate how YY1 regulates activity of the CXCR4 promoter, we transfected A3.01 CD4+ T cells with a CXCR4 promoter/luciferase reporter construct along with a YY1 expression vector. The cells were either unstimulated or stimulated with PMA and ionomycin immediately after transfection, and cell lysates were tested for luciferase activity 2 days later. Overexpression of YY1 suppressed the CXCR4 promoter in A3.01 cells up to 80% in a dose-dependent manner (Fig. 6GoA).



View larger version (16K):
[in this window]
[in a new window]
  		FIGURE 6. YY1 represses CXCR4 promoter activity. A, Overexpression of YY1 down-regulates CXCR4 promoter. A3.01 cells were cotransfected with either pGL-CXCR4(-357) ({square}) or pGL-CXCR4{Delta}YY1 (•) along with the indicated amounts of pCMV-YY1. Total amounts of transfected plasmid DNA were adjusted by adding pCMV. Cells were incubated without any stimulation, and harvested 48 h after transfection for luciferase assays. Representative results from three independent experiments are shown. B, Mutation on the YY1 binding site increases CXCR4 promoter activity. A3.01 cells were transfected with 10 µg of either pGL-CXCR4(-357), pGL-CXCR4{Delta}YY1, or pGL-CXCR4{Delta}E box as well as 10 µg of pCMV-ß-gal, incubated without any stimulation, and luciferase activity was determined in the cell lysates 48 h after transfection. The amounts of cell lysates were standardized by ß-galactosidase activity in the lysates. Results are means and SDs from four independent experiments.

 
To determine whether the YY1 binding site on the CXCR4 promoter sequence involves YY1-mediated repression of the CXCR4 promoter, site-directed mutations were introduced on the YY1 binding site, and its activity was compared with that of wild-type promoter. An oligonucleotide with mutations on the YY1 binding site (L-YY1-m1 in Table IGo) lost its ability to disrupt the YY1 complex formation in gel-mobility shift assays (Fig. 5GoB). Introduction of mutations into the CXCR4 promoter/luciferase reporter construct resulted in approximately a 2-fold increase in the basal activity (Fig. 6GoB), and its activity was not markedly influenced by cotransfection with the YY1 expression vector (Fig. 6GoA). These results indicate that YY1 inhibits the expression of the CXCR4 promoter through its binding to a site around -300 relative to the TSS.

c-Myc and YY1 mutually inhibit the transregulatory functions on the CXCR4 promoter

YY1 has been shown to physically associate with c-Myc, and the interaction between the two proteins appears to result in mutual inhibition of their transregulatory functions (37). To investigate whether these two transcription factors mutually affect their functions related to CXCR4 promoter activity, expression vectors for YY1 and c-Myc were transfected into A3.01 cells individually or in combination along with pGL-CXCR4(-357). As shown above, overexpression of YY1 repressed, while c-Myc transactivated, the CXCR4 promoter activity; however, the net effect of the cotransfection of both expression vectors on the promoter was negligible (Fig. 7Go), implying their mutually inhibitory interaction.



View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 7. c-Myc and YY1 mutually inhibit the transregulatory functions on the CXCR4 promoter. Forty million PBMCs were transfected with 20 µg of pGL-CXCR4(-357), 10 µg of pBpuro-c-myc-ER, and 10 µg of either pCMV or pCMV-YY1. The transfected cells were either untreated (control) or treated (Myc) with 10 nM of 4-hydroxytamoxifen 24 h after transfection. Cells were harvested 48 h after transfection for luciferase assays. Fold induction indicates luciferase activity relative to basal promoter activity. Results were representative of three independent experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In this study, we have demonstrated that cellular YY1 transcription factor down-regulates CXCR4 expression through its interaction with the CXCR4 promoter. Previous studies demonstrated that T cell activation with IL-2 or anti-CD3 Ab increased CXCR4 expression (24, 36), and a cellular transcription factor, NRF-1, is critical for CXCR4 promoter activity (24). YY1 is the first cellular factor to be identified as a repressor of CXCR4 expression.

YY1 is widely expressed and highly conserved among mammalian species, and thus can be categorized as a ubiquitous transcription factor (8, 30). YY1 can directly interact with a wide array of cellular and viral proteins and regulates a number of cellular and viral promoters, depending on the gene as well as the cell type in question (reviewed in 8). For example, YY1 has been shown to associate with the c-Myc protein, and this association may lead to mutual inhibition of the transcription functions of both proteins (37). The c-Myc protein is a potent regulator of cell growth and differentiation, and c-Myc expression is down-regulated upon differentiation of cells of the monocyte/macrophage lineage into more mature phenotypes (38). Considering the relatively weak affinity of c-Myc protein to the CXCR4 promoter E box, we hypothesized that this oncoprotein may activate CXCR4 promoter primarily through the relief of repression mediated by YY1, as has been reported in other promoter contexts (30). Our hypothesis was supported by the results shown in Fig. 7Go. In contrast to c-Myc, other bHLHZip transcription factors, USF1 and USF2, which have higher affinity for the CXCR4 promoter E box than does c-Myc and are not known to interact with YY1, appear to act through their direct binding to the E box.

Other cellular proteins associated with YY1 include cyclophilin A (CyPA) and FK506-binding protein 12 (39). These two proteins specifically interact with YY1 and alter its transcriptional activity, and cyclosporin A and FK506 efficiently disrupt the YY1-CyPA and YY1-FK506-binding protein 12 interactions, respectively (39). It has also been shown that CyPA binds the HIV-1 Gag protein, is specifically incorporated into HIV-1 virion particles, and is required for efficient uncoating of the virions after cellular entry (40, 41). Therefore, it is possible that YY1 influences maturation and uncoating of the HIV-1 virions through interaction with CyPA. Furthermore, YY1 is one of a few cellular transcription factors known to repress HIV LTR transcription activity (9, 10). Taken together, YY1 may affect replication of HIV-1 at several different stages: it may inhibit viral fusion/entry through down-regulation of expression of CXCR4, a fusion/entry cofactor for T-tropic HIV-1; it may inhibit uncoating of virions through interaction with CyPA; and it may inhibit viral expression through down-regulation of HIV-1 LTR activity. It remains unknown whether the transcription factors investigated in this study can actually modulate cell surface expression of CXCR4 and fusogenicity of cells with T-tropic HIV Env; however, preliminary studies have shown that overexpression of YY1 can markedly decrease cell surface expression of CXCR4 (D. Margolis, unpublished observation). Thus, it is likely that YY1-mediated down-regulation of CXCR4 can modulate fusion/entry of T-tropic HIV-1.

Cellular entry is one of the critical events during the HIV-1 replication cycle. A recent study demonstrating that levels of expression of CCR5, a fusion/entry cofactor for macrophage-tropic HIV-1 (11, 12, 13, 15, 16), correlate with infectability of CD4+ T cells by macrophage-tropic HIV-1 in vitro (42) implies that levels of CXCR4 expression may also influence infectability of cells with T-tropic HIV-1. In addition, from previous studies demonstrating that SDF-1, a natural ligand for CXCR4, inhibits cellular entry of T-tropic HIV-1 (19, 20) as well as a recent study showing that a genetic variation in the SDF-1 gene is associated with prognosis of HIV disease (43), it is very likely that availability of functional CXCR4 is one of the critical parameters that determine the rate of progression of HIV disease in vivo. Therefore, it is important to understand the molecular and cellular mechanisms whereby expression of HIV fusion/entry cofactors is regulated. Further characterization of the promoter regions for these cofactors will help delineate the molecular mechanisms that control their expression.



View larger version (66K):
[in this window]
[in a new window]
  		FIGURE 2. DNase I footprinting with nuclear extracts from A3.01 cells. Lanes 1, 4, and 7, G+A chemical cleavage ladder; lanes 2, 3, 5, 6, 8, and 9, DNA fragment pattern generated by DNase I treatment after incubation of a 5' end-labeled probe in the presence of BSA (lanes 2, 5, and 8) or A3.01 nuclear extracts (NE) (lanes 3, 6, and 9). Positions relative to the TSS are shown on the left. The boxes and dots on the right indicate the protected regions (FP-1 through 7 (Fig. 1Go, bottom)) and the hypersensitive nucleotides, respectively.

 

   Acknowledgments
 
We thank T. D. Littlewood, D. E. Ayer, M. Sawadogo, and T. Shenk for reagents, and J. Weddle for graphic work.


   Footnotes
 
1 M.M. and H.M. contributed equally to this project. Back

2 Address correspondence and reprint requests to Dr. H. Moriuchi, Department of Pediatrics, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Back

3 Abbreviations used in this paper: LTR, long terminal repeat; bHLHZip, basic region-helix-loop-helix-zipper; CyPA, cyclophilin A; NRF-1, nuclear respiratory factor-1; SDF-1, stromal-derived factor-1; TSS, transcription start site; YY1, Yin-Yang 1. Back

Received for publication October 2, 1998. Accepted for publication February 16, 1999.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Fauci, A. S.. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529.[Medline]
  2. Nabel, G., D. Baltimore. 1988. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711.
  3. Ruocco, M. R., X. Chen, C. Ambrosino, E. Dragonetti, W. Liu, M. Mallardo, G. De Falco, C. Palmieri, G. Franzoso, I. Quinto, et al 1996. Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6) and NF-{kappa}B/Rel transcription factors. J. Biol. Chem. 271:22479.[Abstract/Free Full Text]
  4. Henderson, A. J., X. Zou, K. L. Calame. 1995. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69:5337.[Abstract]
  5. Jones, K. A., J. T. Kadonaga, P. A. Luciw, R. Tjian. 1986. Activation of the AIDS retrovirus promoter by the cellular transcription factor Sp1. Science 232:755.[Abstract/Free Full Text]
  6. d’Adda di Fagagna, F. D., G. Marzio, M. I. Gutierrez, L. Y. Kang, A. Falaschi, M. Giacca. 1995. Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 69:2765.[Abstract]
  7. Nabel, G. J.. 1993. The role of cellular transcription factors in the regulation of human immunodeficiency virus gene expression. B. R. Cullen, ed. Human Retroviruses 49.-73. IRL Press, Oxford.
  8. Shrivastava, A., K. Calame. 1994. An analysis of genes regulated by the multi-factorial transcriptional regulator Yin Yang-1. Nucleic Acids Res. 22:5151.[Free Full Text]
  9. Margolis, D. M., M. Somasundaran, M. R. Green. 1994. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production. J. Virol. 68:905.[Abstract/Free Full Text]
  10. Romerio, F., M. N. Gabriel, D. M. Margolis. 1997. Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF. J. Virol. 71:9375.[Abstract]
  11. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1{alpha}, MIP-1ß receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955.[Abstract]
  12. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, et al 1996. The ß-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.[Medline]
  13. Deng, D., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, et al 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.[Medline]
  14. Deng, H., D. Unutmaz, V. Kewal Ramani, D. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296.[Medline]
  15. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, R. W. Dom. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the ß-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149.[Medline]
  16. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667.[Medline]
  17. Feng, Y., C. Broder, P. E. Kennedy, E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872.[Abstract]
  18. Liao, F., G. Alkhatib, K. Peden, G. Sharma, E. Berger, J. Farber. 1997. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185:2015.[Abstract/Free Full Text]
  19. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829.[Medline]
  20. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D. F. Legler, et al 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833.[Medline]
  21. Amara, A., S. L. Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetsher, M. Baggiolini, J.-L. Virelizier, F. Arenzana-Seisdedos. 1997. HIV coreceptor down-regulation as antiviral principle: SDF-1{alpha}-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139.[Abstract/Free Full Text]
  22. Signoret, N., J. Oldridge, A. Pelchen-Matthews, P. J. Klasse, T. Tran, L. F. Brass, M. M. Rosenkilde, T. W. Schwartz, W. Holmes, W. Dallas, et al 1997. Phorbol esters and SDF-1 induce rapid endocytosis and down-modulation of the chemokine receptor CXCR4. J. Cell Biol. 139:651.[Abstract/Free Full Text]
  23. Loetscher, P., M. Sietz, M. Baggiolini, B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.[Abstract/Free Full Text]
  24. Moriuchi, M., H. Moriuchi, W. Turner, A. S. Fauci. 1997. Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. J. Immunol. 159:4322.[Abstract]
  25. McKnight, A., D. Wilkinson, G. Simmons, S. Talbot, L. Picard, M. Ahuja, M. Marsh, J. A. Hoxie, P. R. Clapham. 1997. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J. Virol. 71:1692.[Abstract]
  26. Moriuchi, H., M. Moriuchi, J. I. Cohen. 1994. The RING finger domain of the varicella-zoster virus open reading frame 61 protein is required for its transregulatory functions. Virology 205:238.[Medline]
  27. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686.[Abstract/Free Full Text]
  28. Ayer, D. E., C. D. Laherty, Q. A. Lawrence, A. P. Armstrong, R. N. Eisenman. 1996. Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16:5772.[Abstract]
  29. Meier, J. L., X. Luo, M. Sawadogo, S. E. Straus. 1994. The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol. Cell. Biol. 14:6896.[Abstract/Free Full Text]
  30. Shi, Y., E. Seto, Chang L.-S., T. Shenk. 1991. Transciptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67:377.[Medline]
  31. Moriuchi, H., M. Moriuchi, C. Combadiere, P. M. Murphy, A. S. Fauci. 1996. CD8+ T-cell-derived factor(s), but not ß-chemokines RANTES, MIP-1{alpha}, and MIP-1ß, suppress HIV-1 replication in monocytes/macrophages. Proc. Natl. Acad. Sci. USA 93:15341.[Abstract/Free Full Text]
  32. Moriuchi, H., M. Moriuchi, A. S. Fauci. 1997. Nuclear factor-{kappa}B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:3483.[Abstract]
  33. Moriuchi, H., M. Moriuchi, J. I. Cohen. 1995. Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein. J. Virol. 69:4693.[Abstract]
  34. Moriuchi, H., M. Moriuchi, A. S. Fauci. 1997. Cloning and analysis of the promoter region for CCR5, a coreceptor for HIV-1 entry. J. Immunol. 159:5441.[Abstract]
  35. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differently expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925.[Abstract/Free Full Text]
  36. Luscher, B., M. Austin, A. Sommer, S. Hilfenhaus, M. Henriksson. 1996. Transcriptional regulation by the Myc-Max/Mad network. A. G. Papavassiliou, ed. Transcription Factors in Eukaryotes R. G. Land Company, New York.
  37. Shrivastava, A., S. Saleque, G. V. Kalpana, S. Artandi, S. P. Goff, K. Calame. 1993. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262:1889.[Abstract/Free Full Text]
  38. Ayer, D. E., R. N. Eisenman. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7:2110.[Abstract/Free Full Text]
  39. Yang, W.-M., C. J. Inouye, E. Seto. 1995. Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. J. Biol. Chem. 270:15187.[Abstract/Free Full Text]
  40. Franke, E. K., H. E. H. Yuan, J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359.[Medline]
  41. Thali, M., A. Bukovsky, E. Kondo, B. Rosenwirth, C. T. Walsh, J. Sodroski, H. G. Gottlinger. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363.[Medline]
  42. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Neuman, R. A. Koup, C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1681.[Abstract/Free Full Text]
  43. Winkler, C., W. Modi, M. W. Smith, G. W. Nelson, X. Wu, M. Carrington, M. Dean, T. Honjo, K. Tashiro, D. Yabe, et al 1998. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), and San Francisco City Cohort (SFCC). Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279:389.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 GutHome page
R M Thomas, J Kim, M P Revelo-Penafiel, R Angel, D W Dawson, and A M Lowy
The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia
Gut, November 1, 2008; 57(11): 1555 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. De La Luz Sierra, P. Gasperini, P. J. McCormick, J. Zhu, and G. Tosato
Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells
Blood, October 1, 2007; 110(7): 2276 - 2285.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
Y. Zhang, M. Wittner, H. Bouamar, P. Jarrier, W. Vainchenker, and F. Louache
Identification of CXCR4 as a New Nitric Oxide-Regulated Gene in Human CD34+ Cells
Stem Cells, January 1, 2007; 25(1): 211 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B.-C. Lee, T.-H. Lee, R. Zagozdzon, S. Avraham, A. Usheva, and H. K. Avraham
Carboxyl-Terminal Src Kinase Homologous Kinase Negatively Regulates the Chemokine Receptor CXCR4 through YY1 and Impairs CXCR4/CXCL12 (SDF-1{alpha})-Mediated Breast Cancer Cell Migration
Cancer Res., April 1, 2005; 65(7): 2840 - 2845.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Nguyen, X. Zhang, N. Olashaw, and E. Seto
Molecular Cloning and Functional Characterization of the Transcription Factor YY2
J. Biol. Chem., June 11, 2004; 279(24): 25927 - 25934.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
O. Kalayci, E. Birben, L. Wu, T. Oguma, K. Storm van's Gravesande, V. Subramaniam, H. K. Sheldon, E. S. Silverman, and C. M. Lilly
Monocyte Chemoattractant Protein-4 Core Promoter Genetic Variants: Influence on YY-1 Affinity and Plasma Levels
Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 750 - 756.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. Oberley, D. R. Inman, and P. J. Farnham
E2F6 Negatively Regulates BRCA1 in Human Cancer Cells without Methylation of Histone H3 on Lysine 9
J. Biol. Chem., October 24, 2003; 278(43): 42466 - 42476.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Moriuchi and H. Moriuchi
YY1 Transcription Factor Down-regulates Expression of CCR5, a Major Coreceptor for HIV-1
J. Biol. Chem., April 4, 2003; 278(15): 13003 - 13007.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Libura, J. Drukala, M. Majka, O. Tomescu, J. M. Navenot, M. Kucia, L. Marquez, S. C. Peiper, F. G. Barr, A. Janowska-Wieczorek, et al.
CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion
Blood, September 18, 2002; 100(7): 2597 - 2606.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. Kury, R. Greiner-Petter, C. Cornely, T. Jurgens, and H. W. Muller
Mammalian Achaete Scute Homolog 2 Is Expressed in the Adult Sciatic Nerve and Regulates the Expression of Krox24, Mob-1, CXCR4, and p57kip2 in Schwann Cells
J. Neurosci., September 1, 2002; 22(17): 7586 - 7595.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. D. CRISTILLO, H. C. HIGHBARGER, R. L. DEWAR, D. S. DIMITROV, H. GOLDING, and B. E. BIERER
Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element
FASEB J, March 1, 2002; 16(3): 354 - 364.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M. H. Naghavi, M. C. Estable, S. Schwartz, R. G. Roeder, and A. Vahlne
Upstream stimulating factor affects human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in a cell-specific manner, independently of the HIV-1 subtype and the core-negative regulatory element
J. Gen. Virol., March 1, 2001; 82(3): 547 - 559.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
W. Xing and M. Ram Sairam
Characterization of Regulatory Elements of Ovine Follicle-Stimulating Hormone (FSH) Receptor Gene: The Role of E-Box in the Regulation of Ovine FSH Receptor Expression
Biol Reprod, February 1, 2001; 64(2): 579 - 589.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
A. Hasegawa, M. Yasukawa, I. Sakai, and S. Fujita
Transcriptional Down-Regulation of CXC Chemokine Receptor 4 Induced by Impaired Association of Transcription Regulator YY1 with c-Myc in Human Herpesvirus 6-Infected Cells
J. Immunol., January 15, 2001; 166(2): 1125 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. T. Valente, C. Chanel, J. Dumonceaux, R. Olivier, S. Marullo, P. Briand, and U. Hazan
CXCR4 Is Down-Regulated in Cells Infected with the CD4-Independent X4 Human Immunodeficiency Virus Type 1 Isolate m7NDK
J. Virol., January 1, 2001; 75(1): 439 - 447.
[Abstract] [Full Text]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriuchi, M.
Right arrow Articles by Fauci, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriuchi, M.
Right arrow Articles by Fauci, A. S.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS